Idorsia Ltd. · SIX:IDIA
Idorsia — Fact Sheet (December 2022)
6 slides from Idorsia's fact sheet, December 2022
Slide 1: Idorsia Company Profile
Idorsia Company Profile Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. The
Slide 2: Share Information and Company Strategy
Share Information Company Strategy Idorsia was incorporated in March 2017 We will develop Idorsia into one of Europe’s Bring Idorsia to sustainable profitability and listed on the SIX Swiss Exchange (ticker leading biopharmaceutical companies, with We are building Idorsia with a long-term symbol: ID
Slide 3: Innovation portfolio
Innovation portfolio Product / compound Mechanism of action Disease area Status QUVIVIQ™ / Dual orexin receptor antagonist Insomnia Commercially available as QUVIVIQ™ in the US, Daridorexant and the first countries in Europe Approved in Switzerland Under review in Canada Phase 3 in Japan successful
Slide 4: Partnerships
Partnerships Johnson & Johnson Neurocrine In 2017, Idorsia and Actelion Pharmaceuticals, one of the Janssen In 2020, Idorsia entered into a global license agreement with Pharmaceutical Companies of Johnson & Johnson, entered into Neurocrine Biosciences for the development and commercialization a rev
Slide 5: Company milestones
Company milestones 2022 January The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults 2019 December QUVIVIQ (daridorexant) with insomnia November Collaboration Agreement with approved in Switzerland Halozyme (formerly Antares Pharma) for the
Slide 6: About Idorsia and contact details
Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. It is headquartered in Allschwil/Basel, Switzerland and is quoted on the SIX Swiss Exc